dosage form intravenously

摘要

dosage form IV, characterized by one or more pharmaceutical principiosactivos at least partially dissolved in an aqueous suspending medium and where estaproporción undissolved active ingredient has an average particle size 5 .mu.m, corresponding laproporción of particles with a size of between more than 2 .mu.m and 100 .mu.m at least 80% of the totalde mass said particles, and where this proportion of undissolved active ingredient has a maximum size talque, if dilution to 500 ml of phosphate buffer solution body temperature was disuelvedentro a predetermined time administration.